IFT88 and age-related macular degeneration: Postmortem retina sections from multiple AMD low-risk Y402 and high-risk Y402H individuals with no sign of disease [unrelated males between 52 and 68 y old (30)] were compared with respect to IFT52/OSM-6, IFT88/OSM-5, and rhodopsin localization.